首页> 外国专利> MiRNA-based predictive models for diagnosis and prognosis of prostate cancer

MiRNA-based predictive models for diagnosis and prognosis of prostate cancer

机译:基于MiRNA的前列腺癌诊断和预后预测模型

摘要

The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of recurrence after radical prostatectomy would advance the field of prostate cancer treatment. Disclosed are miRNAs that can be used as molecular biomarkers to detect or predict the progression of prostate cancer and to adjust a treatment plan accordingly. Furthermore, kits are included for the detection of these miRNAs.
机译:缺乏明确的前列腺癌进展预测因子会导致对治疗过程的主观决策。鉴定可预测前列腺癌根治术后复发的新生物标志物将推动前列腺癌治疗领域的发展。公开了可用作分子生物标记物以检测或预测前列腺癌的进展并相应地调整治疗计划的miRNA。此外,还包括用于检测这些miRNA的试剂盒。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号